A Phase 1 Cross-over Study to Determine Food Effects on the Pharmacokinetics of Oral BTD-001 and Metabolites in Healthy Volunteers, Followed by an Optional Multiple Dose Study to Assess Pharmacokinetics of Oral BTD-001
Phase of Trial: Phase I
Latest Information Update: 27 Oct 2017
Price : $35 *
At a glance
- Drugs Pentylenetetrazole (Primary)
- Indications Hypersomnia; Narcolepsy
- Focus Pharmacokinetics
- Sponsors Balance Therapeutics
- 20 Oct 2017 Status changed from active, no longer recruiting to completed.
- 17 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 16 May 2017 New trial record